These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2492380

  • 1. Treatment of factor VIII inhibitors.
    Kasper CK.
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract] [Full Text] [Related]

  • 2. Acquired hemophilia.
    Bouvry P, Recloux P.
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [Abstract] [Full Text] [Related]

  • 3. Acquired inhibitors.
    Cohen AJ, Kessler CM.
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [Abstract] [Full Text] [Related]

  • 4. [Successful treatment of massive hemorrhagic diathesis caused by Factor VIII:C-antibodies with adsorption plasmapheresis and immunosuppression].
    Mondorf W, Grützmacher P, Schmidt H, Wolff B, Scharrer I, von Baum H.
    Med Klin (Munich); 1991 Mar 15; 86(3):165-70, 171. PubMed ID: 1903498
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
    José Aguado M, Carrasco V, Periago A, Bello T, González E, García-Talavera J.
    Sangre (Barc); 1996 Apr 15; 41(2):147-50. PubMed ID: 9045356
    [Abstract] [Full Text] [Related]

  • 7. Factor VIII inhibitors.
    Lollar P, Healey JF, Barrow RT, Parker ET.
    Adv Exp Med Biol; 2001 Apr 15; 489():65-73. PubMed ID: 11554592
    [No Abstract] [Full Text] [Related]

  • 8. [Factor VIII inhibitors--their characteristics and clinical significance].
    Dmoszyńska A, Kniaź M, Sokołowska B.
    Pol Arch Med Wewn; 1987 Dec 15; 78(6):333-40. PubMed ID: 3152083
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B, Mahendra A, Dimitrov JD, Friboulet A, Borel-Derlon A, Rao DN, Uda T, Borg JY, Bayry J, Kaveri SV, Lacroix-Desmazes S.
    FEBS Lett; 2009 Aug 06; 583(15):2565-72. PubMed ID: 19595998
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors to clotting factors.
    Sallah S.
    Ann Hematol; 1997 Aug 06; 75(1-2):1-7. PubMed ID: 9322677
    [Abstract] [Full Text] [Related]

  • 13. Anti-idiotypes against autoantibodies to procoagulant factor VIII (VIII:C) in intravenous immunoglobulins.
    Kazatchkine MD, Rossi F, Sultan Y, Nydegger U.
    Int Rev Immunol; 1989 Aug 06; 5(2):157-63. PubMed ID: 8691048
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of hemophilia.
    Meili EO.
    Schweiz Med Wochenschr Suppl; 1991 Aug 06; 43():82-9. PubMed ID: 1843043
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy.
    Toepfer M, Rommel F, Sitter T, Spannagl M, Held E, Schramm W, Schiffl H.
    Thromb Haemost; 1998 Dec 06; 80(6):1035-6. PubMed ID: 9869185
    [No Abstract] [Full Text] [Related]

  • 20. [A rare disease but with a very high hemorrhagic risk: acquired hemophilia A].
    Delisle V, Ternisien C, Beurrier P, Zandecki M.
    Ann Biol Clin (Paris); 2000 Dec 06; 58(6):741-4. PubMed ID: 11098173
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.